β¨ Health Notices
29 MARCH 2007 NEW ZEALAND GAZETTE, No. 35
901
Health
Crown Entities Act 2004
Appointment to the Crown Health Financing Agency
Pursuant to section 28(1)(a) of the Crown Entities Act 2004,
I have appointed
Kay McKelvie
as a member of the Crown Health Financing Agency for
a three-year term of office commencing on 1 March 2007.
This appointment was made by way of written notice to the
member (with a copy to the entity) pursuant to section 28(2)
of the Crown Entities Act 2004.
Dated at Wellington this 15th day of March 2007.
PETE HODGSON, Minister of Health.
go2089
Appointment to the Crown Health Financing Agency
Pursuant to section 28(1)(a) of the Crown Entities Act 2004,
I have appointed
David Moore
as a member of the Crown Health Financing Agency for
a three-year term of office commencing on 1 March 2007.
This appointment was made by way of written notice to the
member (with a copy to the entity) pursuant to section 28(2)
of the Crown Entities Act 2004.
Dated at Wellington this 15th day of March 2007.
PETE HODGSON, Minister of Health.
go2088
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:
Schedule
Product:
Apo-Ipravent Nasal Spray 0.03%
Active Ingredient:
Ipratropium bromide monohydrate 0.3g/L
Dosage Form:
Nasal spray solution
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Richmond Hill, Ontario, Canada
Product:
Apo-Ipravent Nasal Spray 0.06%
Active Ingredient:
Ipratropium bromide monohydrate 0.6g/L
Dosage Form:
Nasal spray solution
New Zealand Sponsor:
Apotex NZ Limited
Manufacturer:
Apotex Inc, Richmond Hill, Ontario, Canada
Product:
Panadol Cold & Flu Citrus
Active Ingredient:
Paracetamol 500mg
Dosage Form:
Effervescent tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
GlaxoSmithKline Dungarvan Limited, Knockbrack, Dungarvan, Co. Waterford, Ireland
Product:
Vicks VapoRub Cream
Active Ingredients:
Camphor 5.23%w/w
Eucalyptus oil 1.35%w/w
Menthol 2.82%w/w
Dosage Form:
Topical cream
New Zealand Sponsor:
Procter & Gamble Distributing New Zealand
Manufacturer:
Procter & Gamble Manufactura S. De R L de C.V. Col. San Francisco Cuautlalpan, Naucalpan Edo De Mexico C.P., Mexico
Dated this 22nd day of March 2007.
CYNTHIA MALING, Acting-Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health
on 6 July 2001).
go2026
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new related product set out in the Schedule hereto:
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 35
Gazette.govt.nz —
NZ Gazette 2007, No 35
β¨ LLM interpretation of page content
π₯ Appointment to the Crown Health Financing Agency
π₯ Health & Social Welfare15 March 2007
Appointment, Crown Health Financing Agency, Member
- Kay McKelvie, Appointed member of Crown Health Financing Agency
- Pete Hodgson, Minister of Health
π₯ Appointment to the Crown Health Financing Agency
π₯ Health & Social Welfare15 March 2007
Appointment, Crown Health Financing Agency, Member
- David Moore, Appointed member of Crown Health Financing Agency
- Pete Hodgson, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare22 March 2007
Medicines, Distribution, Consent, New Medicines
- Cynthia Maling, Acting-Deputy Director-General, Public Health
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social WelfareMedicines, Distribution, Consent, Related Product